Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka
Mohammed Murad Hossain, Associate Professor at National Institute of Cancer Research and Hospital, shared a post on LinkedIn:
“The 2nd Haematology and HSCT Workshop, a two-day (5th and 6th August ) scientific program jointly organized by the Haematology Society of Bangladesh (HSB) and Evercare Hospital, Dhaka, was an outstanding learning experience.
The program was highly interactive, engaging, and full of thought-provoking discussions, practical insights, and stimulating academic exchanges.
It was truly inspiring to see young hematologists from different corners of the country present their topics,ideas and share their knowledge with such confidence and clarity. Their presentations reflected a scientific standard comparable to that of many international meetings.
A special note of appreciation to Professor Abu Jafar Mohammed Saleh Sir for conducting the question-and-answer sessions so skillfully. His enthusiasm, wit, and insightful moderation kept every session lively, interactive, and intellectually enriching.
Congratulations to the organizers, speakers, and participants for making this workshop a memorable academic event. Looking forward to many more such initiatives to advance hematology and HSCT in Bangladesh.”

Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery